Publication date: Dec 14, 2019
MS is a difficult disease to diagnose as it can present in many different ways and lacks an attributable biomarker to assess, said Andrew Solomon, MD, associate professor of neurological sciences and division chief of multiple sclerosis at Larner College of Medicine, The University of Vermont, Burlington, Vermont.
- How Can We Apply Guidelines in the Rapidly Changing MS Treatment Landscape?
- MS Momentum – 04-12-2019 – Karen Collings – Team Leader from Access Ability
- Researchers Find Link Between Herpes Strain And Developing Multiple Sclerosis